LIC MF Healthcare Fund Direct Growth
Equity
Direct
Sector - Healthcare
NAV: ₹ 25.46 as on 18-04-2024
Fund Performance
21 people have invested ₹ 1.6L in LIC MF Healthcare Fund Direct Growth in the last three months
Mutual Fund Insights
Over the last 6 months, this fund has experienced a 22.5% growth in AUM moving from 50.38 Cr to 61.69 Cr.
In the last 5 years, DSP Healthcare Fund Direct Growth has given 27.27% return, outperforming this fund by 6.92% per annum.
In the last 3 years, SBI Healthcare Opportunities Fund Direct Growth has given 19.68% return, outperforming this fund by 6.92% per annum.
This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 1.21% which is lower than the category average expense ratio of 1.42%.
In the last 1 year, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given 60.01% return, outperforming this fund by 13.67%.
INDmoney Rank of LIC MF Healthcare Fund Direct Growth
Powered by IND quant engine
IND ranking is not available for this fund.
Pros
Beats FD returns for both 3Y & 5Y duration
Cons
5Y returns in the bottom 25% of the category
3Y returns in the bottom 25% of the category
About the LIC MF Healthcare Fund Direct Growth
LIC MF Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 February, 2019. The fund is managed by Karan Doshi. The fund could potentially beat inflation in the long-run.
Key Parameters
- LIC MF Healthcare Fund Direct Growth has ₹62 Cr worth of assets under management (AUM) as on Mar 2024 and is less than category average.
- The fund has an expense ratio 1.2.
LIC MF Healthcare Fund Direct Growth Overview
 | 1.21% |
 Benchmark | S&P BSE Healthcare PR |
 | ₹62 Cr |
 | 28 February, 2019 |
 | ₹5000/₹1000 |
 Exit Load | 1% |
 | No Lock-in |
 TurnOver | 414.8% |
LIC MF Healthcare Fund Direct Growth Distribution as on (31-Mar-24)
Size breakup
Large cap
43.9%
Mid cap
25.7%
Small cap
25.3%
Sector Allocation
Health
100%
Top Holdings of LIC MF Healthcare Fund Direct Growth as on (31-Mar-24)
Equity Holdings19
LIC MF Healthcare Fund Direct Growth: Monthly Changes Updates
All changes are between Jan'24 and Mar'24
Fund Performance
- This fund’s returns stands at 0.98% whereas the fund’s underlying benchmark Nifty 500 returns stands at -0.47% as on Mar'24
- This fund outperformed Nifty 500 by 1.45% in Mar'24
AUM Change
- AUM of the fund stands at 61.4 Cr as of Mar'24
- AUM has remained same between Mar'24 and Feb'24
Fund Portfolio Changes
Gainers & Losers in LIC MF Healthcare Fund Direct Growth portfolio Returns for the month of Mar
Top Growth Drivers | 1M Return |
|---|---|
 J B Chemicals & Pharmaceuticals Ltd | 16% |
Peer Analysis
LIC MF Healthcare Fund Direct Growth Fund Manager
Karan Doshi
Fund Manager of LIC MF Healthcare Fund Direct Growth, since 31 July 2023
Top funds managed
LIC MF Healthcare Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 20.13% since inception which is less than its category average return of 20.36%
Fund Allocations
This fund has an allocation of 94.98% in Equity, 0% in Debt and 5.02% in Cash related instruments
AUM size ₹62 Cr
This fund has AUM of ₹62 Cr which is less than its category average of ₹ 1652 Cr
Expense Ratio 1.21%
This fund has an expense ratio of 1.21% which is less than its category average expense ratio of 1.45%
Frequently Asked Questions
The current NAV of LIC MF Healthcare Fund Direct Growth is ₹25.46 as on 18-Apr-2024.
Existing (Absolute + CAGR) as on 18-Apr-2024.
LIC MF Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 4.09% | 4.09% |
6 Month Returns | 26.18% | 26.18% |
1 Year Returns | 46.34% | 46.34% |
3 Years Returns | 43.39% | 12.76% |
5 Years Returns | 152.45% | 20.35% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
1.21% as on March 2024
₹62 Cr as on March 2024
Sun Pharmaceuticals Industries Ltd(14.88%), Zydus Lifesciences Ltd(7.46%), J.B. Chemicals & Pharmaceuticals Ltd(6.27%), Piramal Pharma Ltd(5.78%), Cipla Ltd(5.71%) as on March 2024
The alpha ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
LIC MF Healthcare Fund Direct Growth | -2.8 | -2.47 | 1.5 |
As on March 2024
The alpha for LIC MF Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
LIC MF Healthcare Fund Direct Growth | 0.91 | 0.92 | 0.88 |
As on March 2024
The Beta for LIC MF Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
LIC MF Healthcare Fund Direct Growth | 2.57 | 0.65 | 0.84 |
As on March 2024
The sharpe ratio for LIC MF Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
LIC MF Healthcare Fund Direct Growth | 14.16 | 15.08 | 17.95 |
As on March 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.11 as on March 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Karan Doshi is the fund manager of LIC MF Healthcare Fund Direct Growth
The Exit load of LIC MF Healthcare Fund Direct Growth is 1%